このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Edwards Lifesciences バランスシートの健全性
財務の健全性 基準チェック /66
Edwards Lifesciencesの総株主資本は$7.2B 、総負債は$597.2Mで、負債比率は8.3%となります。総資産と総負債はそれぞれ$9.7Bと$2.5Bです。 Edwards Lifesciencesの EBIT は$1.8Bで、利息カバレッジ比率-31.6です。現金および短期投資は$1.7Bです。
主要情報
8.3%
負債資本比率
US$597.20m
負債
| インタレスト・カバレッジ・レシオ | -31.6x |
| 現金 | US$1.70b |
| エクイティ | US$7.19b |
| 負債合計 | US$2.55b |
| 総資産 | US$9.74b |
財務の健全性に関する最新情報
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03Recent updates
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet
Apr 03What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?
Mar 22Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)
Mar 10Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Feb 26Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges
Feb 06Edwards Lifesciences slips as Piper downgrades on challenging setup
Jan 30Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity
Jan 18財務状況分析
短期負債: EWの 短期資産 ( $4.2B ) が 短期負債 ( $1.1B ) を超えています。
長期負債: EWの短期資産 ( $4.2B ) が 長期負債 ( $1.4B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: EW総負債よりも多くの現金を保有しています。
負債の削減: EWの負債対資本比率は、過去 5 年間で17.2%から8.3%に減少しました。
債務返済能力: EWの負債は 営業キャッシュフロー によって 十分にカバー されています ( 88.4% )。
インタレストカバレッジ: EW支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。